T1	Participants 126 142	coronary lesions
T2	Participants 296 333	Patients with Coronary Artery Disease
T3	Participants 953 1022	patients with single de novo coronary lesions treated with ZES or PES
T4	Participants 1208 1222	1,548 patients
